Leveraging Innovation To Deliver Precision Medicines

Jubilant Therapeutics

Jubilant Therapeutics is a patient-centric biopharmaceutical company advancing potent and selective small molecule modulators to address unmet medical needs in oncology and autoimmune diseases.

Our Strategy

Focus on unmet medical needs resulting from specific genetic mutations, drug resistance, or compensatory mechanisms

Build a portfolio of internally discovered and selectively acquired programs structured into asset-based subsidiaries

Fast track promising assets from discovery to clinical proof of concept

Advance programs into pivotal studies and commercialization through creative partnerships

Leverage proven and synergistic capabilities of Jubilant Life Sciences’ world-class research with in-house development expertise


11th-14th Jan, 2021

39th Annual J.P. Morgan Healthcare Conference

Virtual Access to Corporate Presentation and to host 1x1 meetings


We use cookies to recognize your repeat visits and preferences, as well as to measure the effectiveness
of campaigns and analyze traffic. If you continue to use this site we will assume your acceptance.